Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20200923048816N1
IRCT20200923048816N1Recruiting未知

Investigating the effect of adding memantine to current therapies on the symptoms of post-traumatic stress disorder

Esfahan University of Medical Sciences0 sites30 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
30
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 years to 65 years (—)
Sex
All

Inclusion Criteria

  • •Male and female patients with an age range of 19 to 65 years
  • •A case of battlefield PTSD diagnosed at least 12 months in advance according to DSM 5 criteria

Exclusion Criteria

  • •Patients with a history of dementia, schizophrenia, bipolar disorder, anxiety disorders, traumatic brain injury, and seizures according to DSM 5 criteria
  • •Patients with a history of alcohol and psychotropic drug use in the last month or the presence of addiction in the patient's history
  • •Patients need treatment with drugs that affect the glutamatergic system such as amantadine, dexamethasone or carbonic anhydrase inhibitors

Investigators

Similar Trials

Completed
Phase 2
Effect of memantine in treatment of dyslexia
IRCT2016091329807N1Isfahan University of Medical Sciences, Faculty of medicine62
Completed
Phase 2
Evaluation of the efficacy of memantine in children with attention deficit hyperactivity disorderAttention deficit hyperactivity disorder.mental and behavioural disordersF90-F98
IRCT2016080829268N1Vice Chancellor for Research , Arak University of Medical Sciences76
Completed
Phase 3
Investigating the effect of memantine in preventing vasospasm in SAH patients with consciousness level 9-15vasospasm.Other cerebrovascular vasospasm and vasoconstrictionI67.848
IRCT20180826040869N3Mazandaran University of Medical Sciences88
Recruiting
Phase 3
Assessment the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathychemotherapy-induced peripheral neuropathy in patients with cancer.Idiopathic peripheral autonomic neuropathyG90.0
IRCT20160310026998N12Tabriz University of Medical Sciences180
Recruiting
Phase 2
Effect of Cuminum Cyminum on the return of intestinal peristaltic movements after abdominal surgeries
IRCT20150713023190N10Rafsanjan University of Medical Sciences70